AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543 | +85.0% | 62,360 | +112.4% | 0.01% | +100.0% |
| Q2 2023 | $834 | +23.6% | 29,360 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $675 | -22.0% | 29,360 | -4.6% | 0.01% | -28.6% |
| Q4 2022 | $865 | -99.9% | 30,763 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $920,000 | +27.6% | 32,545 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $721,000 | -23.7% | 32,545 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $945,000 | -13.4% | 32,545 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $1,091,000 | -27.4% | 32,545 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $1,502,000 | -16.2% | 32,545 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $1,793,000 | +6.9% | 32,545 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,677,000 | – | 32,545 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |